BMC Medical Genetics (May 2009)

Genetic variation in Fcγ receptor IIa and risk of coronary heart disease: negative results from two large independent populations

  • Khuseyinova Natalie,
  • Winkelmann Bernhard,
  • Meisinger Christa,
  • Rothenbacher Dietrich,
  • Vollmert Caren,
  • Hoffmann Michael M,
  • Karakas Mahir,
  • Böhm Bernhard O,
  • Illig Thomas,
  • März Winfried,
  • Koenig Wolfgang

DOI
https://doi.org/10.1186/1471-2350-10-46
Journal volume & issue
Vol. 10, no. 1
p. 46

Abstract

Read online

Abstract Background The role of the Fcγ receptor IIa (FcγRIIa), a receptor for C-reactive protein (CRP), the classical acute phase protein, in atherosclerosis is not yet clear. We sought to investigate the association of FcγRIIa genotype with risk of coronary heart disease (CHD) in two large population-based samples. Methods FcγRIIa-R/H131 polymorphisms were determined in a population of 527 patients with a history of myocardial infarction and 527 age and gender matched controls drawn from a population-based MONICA- Augsburg survey. In the LURIC population, 2227 patients with angiographically proven CHD, defined as having at least one stenosis ≥ 50%, were compared with 1032 individuals with stenosis Results In both populations genotype frequencies of the FcγRIIa gene did not show a significant departure from the Hardy-Weinberg equilibrium. FcγRIIa R(-131) → H genotype was not independently associated with lower risk of CHD after multivariable adjustments, neither in the MONICA population (odds ratio (OR) 1.08; 95% confidence interval (CI) 0.81 to 1.44), nor in LURIC (OR 0.96; 95% CI 0.81 to 1.14). Conclusion Our results do not confirm an independent relationship between FcγRIIa genotypes and risk of CHD in these populations.